Steinmetz Shimon purchased $17K of ARQ

Steinmetz Shimon (Chief Financial Officer) purchased 7,500 shares of Arq, Inc. (ARQ) at $2.22 on 2026-09-03.

Original reporting
SEC EDGAR · Steinmetz Shimon
Published Sep 8, 2026, 9:32 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 8, 2026, 9:45 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ARQ
Bullish
medium confidence
Mentioned
$ARQ
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ARQBullishLow
01

Why it matters

The filing provides a fresh data point on insider confidence but limited market impact.

02

Market read

Small insider buy; unlikely to move the stock significantly.

03

What to watch

The purchase size is tiny; market may ignore it.

Relevance 4/10Novelty 5/10Timing: filed today

Background

Form 4 filings disclose insider transactions; CFO purchases are monitored for sentiment.

Company-level read

Ticker impact

$ARQBullishMedium confidence
Context

CFO Steinmetz Shimon bought 7,500 shares of ARQ for $16.6K, increasing his stake to 350,523 shares.

Expected impact

Potential slight upside as market digests insider buying.

Evidence & confidence

Purchase size is small relative to market cap, but CFO buying is a positive signal.

Market effects

Minimal impact on the broader sector.

No regional effect.

Negligible.

Counterpoint

Insider purchase may be routine compensation, not a strong bullish indicator.

Key entities

  • Arq, Inc.

    US-listed biotech company (ticker ARQ).

  • Steinmetz Shimon

    Chief Financial Officer of Arq, Inc.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ARQMed

Arq Reports Third Quarter 2026 Results

Arq, Inc. (ARQ) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Arq Reports Third Quarter 2026 Results Achieved record quarterly revenue of $38.2 million (+9% YoY) and Net income of $2.5 million Generated 10 th consecutive quarter of positive Adjusted EBITDA (1) of $8.8 million (+71% YoY) Improved gross margins to 39.7% driven by

$ARQMed

Arq (ARQ) Q2 2026 Earnings Call Transcript

Arq (ARQ) held its Q2 2026 earnings call, citing revenue of about $30 million, gross margin around 38.5% (up ~520 bps), and adjusted EBITDA of about $5.8 million. The company discussed PAC for PFAS for near-term compliance ahead of EPA PFAS rules, and reiterated full-year CapEx of $8 million to $10 million.

$ARQMed

Arq Reports Second Quarter 2026 Results

Arq, Inc. (ARQ) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Arq Reports Second Quarter 2026 Results Generated revenue of approximately $30 million, up 5% Reported Adjusted EBITDA (1) of approximately $5.8 million, up 59% on prior year period 9 th consecutive quarter of positive Adjusted EBITDA, driven by foundational PAC busi

$NATRMed

PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. (FROHLICH PHIL) purchased $2.8M of NATR (indirect holdings)

PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. purchased 291,666 indirectly-held shares of NATURES SUNSHINE PRODUCTS INC (NATR) at an average of $9.77 ($9.50–$9.95, $2.85M total) across 20 trades on 2026-11-05. Filed jointly with PRESCOTT GROUP AGGRESSIVE SMALL CAP LP (10% owner), PRESCOTT GROUP AGGRESSIVE SMALL CAP II LP (10% owner), PRESCOTT GROUP AGGRESSIVE SMALL CAP MASTER FUND GP (10% owner) and FROHLICH PHIL (10% owner).